PharmaShots | Incisive News in 3 Shots

Subscribe Now

CASI Pharmaceuticals

CASI Pharmaceuticals and BioInvent Reveal P-I Study Results of BI-1206 for the Treatment of Non-Hodgkin’s Lymphoma in China

CASI Pharmaceuticals and BioInvent Reveal P-I Study Results of BI-1206 for the Treatment of Non-Hodgkin’s Lymphoma in China

March 6, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us